DEC 14, 2017 6:40 AM PST

Typhoid Fever Toxin Targets Sugary Cells

WRITTEN BY: Kara Marker

A new study from Cornell University explains why the current vaccine for typhoid fever is only partially effective. Salmonella typhi, the bacterial agent responsible for the disease, has eluded scientists aiming to decipher its molecular mechanisms of infection, but the new study, published in the journal Nature Microbiology, uncovers several important details.

Colorized scanning electron micrograph of the foodborne pathogen Salmonella enteritidis, the most common in the United States alongside Salmonella typhimurium.

Even in the 21st century, typhoid fever continues to spread as a result of poor sanitation, affecting over 21 million people worldwide. A typhoid fever infection, which is preventable and treatable with antibiotics, causes symptoms such as fever, weakness, stomach pains, headache, and loss of appetite. Salmonella typhi only lives in humans, carried in the bloodstream and intestinal tract and discarded in feces. The bacteria can live both inside and outside the cells it infects.

When Salmonella typhi live inside cells, they produce the typhoid toxin, which then generates the symptoms characteristic of typhoid fever. The current vaccine for typhoid fever, a drug called Typhoid Vaccine Live Oral Ty21a, is effective against the bacteria but not the toxin.

How does the typhoid toxin work? It searches for cells to intoxicate that express specific sugars, for their binding abilities. This attraction to sugar leads scientists to think that there’s a possibility of intervening at this level.

"Intriguingly, our study shows that the typhoid toxin targets both the immune system and central nervous system," explained senior author Jeongmin Song. "This represents a new paradigm in the infectious agents' incursion of the host."

Song and his team are looking at new, sugar-based treatment options to combine with Ty21a instead of just applying Ty21a alone. This approach could also work for other diseases where microorganisms are attracted to sugars for their binding capabilities.

"What's most exciting is that our results provide insights that may help the development of potential prophylactics and therapeutics to prevent and treat typhoid fever," Song explained.

Sources: CDC, Cornell University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 03, 2020
Immunology
A Low-Cost COVID-19 Treatment, Made in Horses
SEP 03, 2020
A Low-Cost COVID-19 Treatment, Made in Horses
Researchers in Costa Rica are turning to horses as an unlikely source of potential therapeutic antibodies against COVID- ...
SEP 24, 2020
Immunology
Remember That Coronavirus You Once Met? Your T Cells Do.
SEP 24, 2020
Remember That Coronavirus You Once Met? Your T Cells Do.
The SARS-CoV-2 virus was first identified in December 2019 in Wuhan, Hubei, China and quickly escalated to a pandemic st ...
OCT 22, 2020
Immunology
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
OCT 22, 2020
Migraines: Dark Times and (Pharmaceutical) Rays of Hope
Despite being commonly used interchangeably, headaches and migraines are worlds apart. Migraines are by far much more pr ...
OCT 27, 2020
Immunology
The Genetics of Skin Inflammation, Seen With Unprecedented Clarity
OCT 27, 2020
The Genetics of Skin Inflammation, Seen With Unprecedented Clarity
A recent study published in Immunity details MIT scientists’ exploration of the underlying mechanisms of inflammat ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
NOV 16, 2020
Immunology
Measles Is Back and COVID Isn't Helping
NOV 16, 2020
Measles Is Back and COVID Isn't Helping
Measles is a highly contagious and airborne viral disease. There is no treatment besides supportive care once a person b ...
Loading Comments...